Scholars@Duke

Drug companies cut HIV drug prices in the developing world.

Publication ,  Journal Article
Yamey, G
Published in: BMJ (Clinical research ed.)
May 2000
Published version (DOI)

Duke Scholars

Gavin Mark Yamey
Author Gavin Mark Yamey Duke Global Health Institute

Published In

BMJ (Clinical research ed.)

DOI

10.1136/bmj.320.7246.1357

EISSN

1756-1833

ISSN

0959-8138

Publication Date

May 2000

Volume

320

Issue

7246

Start / End Page

1357

Related Subject Headings

  • Humans
  • General & Internal Medicine
  • Drug Industry
  • Developing Countries
  • Costs and Cost Analysis
  • Anti-HIV Agents
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yamey, G. (2000). Drug companies cut HIV drug prices in the developing world. BMJ (Clinical Research Ed.), 320(7246), 1357. https://doi.org/10.1136/bmj.320.7246.1357
Yamey, G. “Drug companies cut HIV drug prices in the developing world.” BMJ (Clinical Research Ed.) 320, no. 7246 (May 2000): 1357. https://doi.org/10.1136/bmj.320.7246.1357.
Yamey G. Drug companies cut HIV drug prices in the developing world. BMJ (Clinical research ed). 2000 May;320(7246):1357.
Yamey, G. “Drug companies cut HIV drug prices in the developing world.” BMJ (Clinical Research Ed.), vol. 320, no. 7246, May 2000, p. 1357. Epmc, doi:10.1136/bmj.320.7246.1357.
Yamey G. Drug companies cut HIV drug prices in the developing world. BMJ (Clinical research ed). 2000 May;320(7246):1357.

Published In

BMJ (Clinical research ed.)

DOI

10.1136/bmj.320.7246.1357

EISSN

1756-1833

ISSN

0959-8138

Publication Date

May 2000

Volume

320

Issue

7246

Start / End Page

1357

Related Subject Headings

  • Humans
  • General & Internal Medicine
  • Drug Industry
  • Developing Countries
  • Costs and Cost Analysis
  • Anti-HIV Agents
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 1117 Public Health and Health Services